| 0 |
JUNCTIONAL ECTOPIC TACHYCARDIA |
3 |
0.0517 |
| 1 |
BEZOLD-JARISCH REFLEX |
1 |
0.0263 |
| 2 |
BURKHOLDERIA TEST POSITIVE |
1 |
0.0081 |
| 3 |
MEAN ARTERIAL PRESSURE DECREASED |
2 |
0.0079 |
| 4 |
ACCELERATED IDIOVENTRICULAR RHYTHM |
1 |
0.0068 |
| 5 |
FEAR OF EATING |
1 |
0.0032 |
| 6 |
NEONATAL HYPOTENSION |
1 |
0.0027 |
| 7 |
ENTEROCOCCAL SEPSIS |
2 |
0.0025 |
| 8 |
RETICULOCYTE COUNT DECREASED |
1 |
0.0023 |
| 9 |
BLAST CELLS PRESENT |
1 |
0.0021 |
| 10 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 11 |
VENTRICULAR DYSFUNCTION |
3 |
0.0012 |
| 12 |
VENTRICULAR ARRHYTHMIA |
4 |
0.0011 |
| 13 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 14 |
PYURIA |
1 |
0.0010 |
| 15 |
CONGESTIVE CARDIOMYOPATHY |
4 |
0.0010 |
| 16 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 17 |
ISCHAEMIC CEREBRAL INFARCTION |
1 |
0.0009 |
| 18 |
HYPOCHLORAEMIA |
1 |
0.0009 |
| 19 |
FEBRILE INFECTION |
1 |
0.0008 |
| 20 |
PHYSICAL DECONDITIONING |
2 |
0.0008 |
| 21 |
PULSELESS ELECTRICAL ACTIVITY |
3 |
0.0007 |
| 22 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 23 |
HEAT STROKE |
1 |
0.0007 |
| 24 |
FOOD AVERSION |
1 |
0.0006 |
| 25 |
HYPERBILIRUBINAEMIA |
6 |
0.0006 |
| 26 |
IMMUNE-MEDIATED LUNG DISEASE |
1 |
0.0005 |
| 27 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 28 |
HAEMODYNAMIC INSTABILITY |
4 |
0.0005 |
| 29 |
HEPATOMEGALY |
5 |
0.0005 |
| 30 |
RADIATION PNEUMONITIS |
1 |
0.0005 |
| 31 |
ATRIOVENTRICULAR BLOCK COMPLETE |
3 |
0.0004 |
| 32 |
ENTEROCOCCAL INFECTION |
2 |
0.0004 |
| 33 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 34 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 35 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 36 |
CARDIOGENIC SHOCK |
5 |
0.0003 |
| 37 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 38 |
RESPIRATORY RATE DECREASED |
1 |
0.0003 |
| 39 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 40 |
HEPATOTOXICITY |
6 |
0.0003 |
| 41 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
2 |
0.0003 |
| 42 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 43 |
ARTERIOSPASM CORONARY |
1 |
0.0002 |
| 44 |
AORTIC DISSECTION |
1 |
0.0002 |
| 45 |
COAGULOPATHY |
4 |
0.0002 |
| 46 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 47 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 48 |
DYSPHORIA |
1 |
0.0002 |
| 49 |
RESPIRATORY ARREST |
5 |
0.0002 |
| 50 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 51 |
CYTOPENIA |
2 |
0.0002 |
| 52 |
BRAIN OEDEMA |
2 |
0.0002 |
| 53 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 54 |
CYTOKINE RELEASE SYNDROME |
3 |
0.0001 |
| 55 |
EXTRASYSTOLES |
1 |
0.0001 |
| 56 |
CARDIOMYOPATHY |
2 |
0.0001 |
| 57 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 58 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 59 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 60 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 61 |
CYANOSIS |
2 |
0.0001 |
| 62 |
HICCUPS |
1 |
0.0001 |
| 63 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 64 |
NEUROTOXICITY |
2 |
0.0001 |
| 65 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 66 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0001 |
| 67 |
HAEMOPTYSIS |
3 |
0.0001 |
| 68 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 69 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 70 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 71 |
BONE MARROW FAILURE |
2 |
0.0001 |
| 72 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 73 |
LACTIC ACIDOSIS |
3 |
0.0001 |
| 74 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 75 |
ASPIRATION |
1 |
0.0001 |
| 76 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 77 |
CARDIAC ARREST |
7 |
0.0001 |
| 78 |
MYELOSUPPRESSION |
3 |
0.0001 |
| 79 |
INTERSTITIAL LUNG DISEASE |
4 |
0.0001 |
| 80 |
PNEUMONIA ASPIRATION |
2 |
0.0001 |
| 81 |
PRODUCT USE ISSUE |
15 |
0.0001 |
| 82 |
HYPOPHAGIA |
2 |
0.0001 |
| 83 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 84 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 85 |
BRONCHOSPASM |
1 |
0.0001 |
| 86 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 87 |
APHASIA |
2 |
0.0001 |
| 88 |
LUNG INFECTION |
1 |
0.0001 |
| 89 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 90 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 91 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 92 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 93 |
HYPERKALAEMIA |
2 |
0.0001 |
| 94 |
HYPOXIA |
2 |
0.0001 |
| 95 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 96 |
LYMPHOCYTE COUNT DECREASED |
1 |
0.0001 |
| 97 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 98 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 99 |
PROTEINURIA |
1 |
0.0001 |
| 100 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0000 |
| 101 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 102 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 103 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 104 |
PRODUCT USE IN UNAPPROVED INDICATION |
12 |
0.0000 |
| 105 |
EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 106 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 107 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 108 |
TACHYCARDIA |
4 |
0.0000 |
| 109 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 110 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 111 |
ARRHYTHMIA |
2 |
0.0000 |
| 112 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 113 |
LIVER INJURY |
1 |
0.0000 |
| 114 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 115 |
LEUKOPENIA |
2 |
0.0000 |
| 116 |
RENAL FAILURE |
5 |
0.0000 |
| 117 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 118 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 119 |
PNEUMONITIS |
1 |
0.0000 |
| 120 |
SKIN LESION |
1 |
0.0000 |
| 121 |
TREATMENT FAILURE |
3 |
0.0000 |
| 122 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 123 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 124 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 125 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 126 |
MATERNAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 127 |
HEPATIC FAILURE |
1 |
0.0000 |
| 128 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 129 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 130 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 131 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 132 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 133 |
FUNGAL INFECTION |
1 |
0.0000 |
| 134 |
HYPOTENSION |
6 |
0.0000 |
| 135 |
DELIRIUM |
1 |
0.0000 |
| 136 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 137 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 138 |
SEPSIS |
3 |
0.0000 |
| 139 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 140 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 141 |
SEIZURE |
3 |
0.0000 |
| 142 |
CARDIAC FAILURE |
2 |
0.0000 |
| 143 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 144 |
TOXICITY TO VARIOUS AGENTS |
4 |
0.0000 |
| 145 |
HYPERTENSION |
5 |
0.0000 |
| 146 |
OVERDOSE |
5 |
0.0000 |
| 147 |
SEPTIC SHOCK |
1 |
0.0000 |
| 148 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 149 |
COMA |
1 |
0.0000 |
| 150 |
SYNCOPE |
2 |
0.0000 |
| 151 |
CONDITION AGGRAVATED |
6 |
0.0000 |
| 152 |
FLUID RETENTION |
1 |
0.0000 |
| 153 |
HAEMORRHAGE |
2 |
0.0000 |
| 154 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 155 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 156 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 157 |
HYPONATRAEMIA |
1 |
0.0000 |
| 158 |
PALPITATIONS |
2 |
0.0000 |
| 159 |
DRUG INEFFECTIVE |
22 |
0.0000 |
| 160 |
STOMATITIS |
1 |
0.0000 |
| 161 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 162 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 163 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 164 |
NEUTROPENIA |
2 |
0.0000 |
| 165 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 166 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 167 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 168 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 169 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 170 |
ANAEMIA |
2 |
0.0000 |
| 171 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 172 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 173 |
PYREXIA |
3 |
0.0000 |
| 174 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 175 |
PSORIASIS |
1 |
0.0000 |
| 176 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 177 |
VOMITING |
3 |
0.0000 |
| 178 |
DRUG INTERACTION |
1 |
0.0000 |
| 179 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 180 |
PNEUMONIA |
2 |
0.0000 |
| 181 |
TREMOR |
1 |
0.0000 |
| 182 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 183 |
COVID-19 |
1 |
0.0000 |
| 184 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 185 |
NAUSEA |
4 |
0.0000 |
| 186 |
SOMNOLENCE |
1 |
0.0000 |
| 187 |
ERYTHEMA |
1 |
0.0000 |
| 188 |
RASH |
2 |
0.0000 |
| 189 |
OFF LABEL USE |
4 |
0.0000 |
| 190 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 191 |
DECREASED APPETITE |
1 |
0.0000 |
| 192 |
DYSPNOEA |
2 |
0.0000 |
| 193 |
ANXIETY |
1 |
0.0000 |
| 194 |
DIARRHOEA |
2 |
0.0000 |
| 195 |
ASTHENIA |
1 |
0.0000 |
| 196 |
PRURITUS |
1 |
0.0000 |
| 197 |
HEADACHE |
1 |
0.0000 |
| 198 |
FATIGUE |
1 |
0.0000 |
| 199 |
DEATH |
1 |
0.0000 |